Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,276,339 papers from all fields of science
Search
Sign In
Create Free Account
cytarabine/daunorubicin/thioguanine
Known as:
SAB regimen
, DAT chemotherapy protocol 1
, TAD
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Broader (3)
Antineoplastic Combined Chemotherapy Protocols
Daunorubicin
Thioguanine
Cytarabine
Daunorubicin Hydrochloride
diameter.transverse
Narrower (1)
TAD regimen
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
High-resolution TADs reveal DNA sequences underlying genome organization in flies
Fidel Ramírez
,
Vivek Bhardwaj
,
+6 authors
T. Manke
Nature Communications
2017
Corpus ID: 3485908
Despite an abundance of new studies about topologically associating domains (TADs), the role of genetic information in TAD…
Expand
Highly Cited
2017
Highly Cited
2017
Comparison of computational methods for Hi-C data analysis
M. Forcato
,
C. Nicoletti
,
Koustav Pal
,
C. Livi
,
F. Ferrari
,
S. Bicciato
Nature Methods
2017
Corpus ID: 3057985
Hi-C is a genome-wide sequencing technique used to investigate 3D chromatin conformation inside the nucleus. Computational…
Expand
Highly Cited
2016
Highly Cited
2016
The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies
C. Redin
,
H. Brand
,
+146 authors
M. Talkowski
Nature Genetics
2016
Corpus ID: 1412545
Despite the clinical significance of balanced chromosomal abnormalities (BCAs), their characterization has largely been…
Expand
Highly Cited
2008
Highly Cited
2008
Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate.
M. Peden‐Adams
,
J. M. Keller
,
J. Eudaly
,
J. Berger
,
G. Gilkeson
,
D. Keil
Toxicological Sciences
2008
Corpus ID: 7212977
Adult male and female B6C3F1 mice were exposed to perfluorooctane sulfonate (PFOS) daily via gavage for 28 days (0, 0.005, 0.05…
Expand
Highly Cited
2006
Highly Cited
2006
The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.
F. Dayan
,
D. Roux
,
M. Brahimi-Horn
,
J. Pouysségur
,
N. Mazure
Cancer Research
2006
Corpus ID: 38247577
The function of the hypoxia-inducible factor-1 (HIF-1), the key transcription factor involved in cellular adaptation to hypoxia…
Expand
Highly Cited
2003
Highly Cited
2003
Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the…
W. Kern
,
T. Haferlach
,
+7 authors
W. Hiddemann
Blood
2003
Corpus ID: 14784094
Risk assessment in acute myeloid leukemia (AML) using pretreatment characteristics may be improved by incorporating parameters of…
Expand
Highly Cited
2001
Highly Cited
2001
One‐year prevalence of subthreshold and threshold DSM‐IV generalized anxiety disorder in a nationally representative sample
Robin M. Carter
,
H. Wittchen
,
H. Pfister
,
R. Kessler
Depression and Anxiety
2001
Corpus ID: 9942397
Several studies of representative populations have reported prevalence rates of DSM‐III and DSM‐III‐R generalized anxiety…
Expand
Highly Cited
2001
Highly Cited
2001
Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients
C. Schoch
,
T. Haferlach
,
+8 authors
W. Hiddemann
British Journal of Haematology
2001
Corpus ID: 25514090
The clinical significance of complex chromosome aberrations for adults with acute myeloid leukaemia (AML) was assessed in 920…
Expand
Highly Cited
2000
Highly Cited
2000
On the late‐time behavior of tracer test breakthrough curves
R. Haggerty
,
S. McKenna
,
L. Meigs
2000
Corpus ID: 62830343
We investigated the late‐time (asymptotic) behavior of tracer test breakthrough curves (BTCs) with rate‐limited mass transfer (e…
Expand
Highly Cited
1999
Highly Cited
1999
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial…
T. Büchner
,
W. Hiddemann
,
+14 authors
A. Heinecke
Blood
1999
Corpus ID: 9582132
Early intensification of chemotherapy with high-dose cytarabine either in the postremission or remission induction phase has…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE